Navigation Links
Academies recommend new measures in antibiotic research

A growing number of infections worldwide are caused by bacteria resistant to antibiotics and ever fewer effective antibiotics are available. As a result, it is becoming increasingly difficult to treat infected patients successfully. In the statement, "Antibiotic Research: Problems and Perspectives", which was published today, the Academy of Sciences and Humanities in Hamburg and the German National Academy of Sciences Leopoldina list eight recommendations that show ways to prevent the further spread of antibiotic resistance and to develop urgently needed antibiotics.

"This development is a cause for grave concern. Our statement focuses on the contribution by research and on the necessary parameters in society," said Prof. Ansgar W. Lohse, spokesperson for the Working Group on Infection Research and Society at the Academy of Sciences and Humanities in Hamburg. "We need genuine incentives for new and more intensive antibiotic research so we can develop medications more quickly," he added.

"This field is a task for society as a whole," said Prof. Jrg Hacker, President of the German National Academy of Sciences Leopoldina. "Society does not only need greater research efforts and a faster translation of the findings into applications, but also dialogue on how antibiotics can be used responsibly and on how resistance can be prevented. We are setting up a round table on this topic and will invite all the relevant partners to join it."

According to the WHO, the global occurrence of antibiotic resistance poses one of the greatest threats to human health. It is estimated that around 25,000 patients die each year in the EU alone from an infection with bacteria that are resistant to antibiotics.

Contact: Caroline Wichmann

Page: 1

Related biology news :

1. Daniel Kahnemans Thinking, Fast and Slow wins best book award from academies
2. National Academies Keck Conference picks NYU-Poly citizen science researcher
3. Radiologists study necessity of additional imaging recommendations in PET/CT oncologic reports
4. Computing advances vital to sustainability efforts; new report recommends problem-focused, iterative approach to research
5. Effectiveness and impact of climate change mitigation measures unclear
6. Development of measures to prevent wine indispositions
7. Researchers attempt to solve problems of antibiotic resistance and bee deaths in one
8. Exposure to antibiotics linked to severity of allergic asthma: UBC research
9. Team discovers how bacteria resist a Trojan horse antibiotic
10. New antibiotic could make food safer and cows healthier
11. Hot on the trail of metabolic diseases and resistance to antibiotics
Post Your Comments:
(Date:11/11/2015)... 11, 2015   MedNet Solutions , an innovative SaaS-based ... research, is pleased to announce that it will be a ... event, to be held November 17-19 in ... live demonstrations of iMedNet , MedNet,s easy-to-use, ... iMedNet has been able to deliver time and cost ...
(Date:11/9/2015)... Nov. 9, 2015  Synaptics Inc. (NASDAQ: SYNA ... announced broader entry into the automotive market with a ... the pace of consumer electronics human interface innovation. Synaptics, ... ideal for the automotive industry and will be implemented ... Europe , Japan , ...
(Date:10/29/2015)... 29, 2015  The J. Craig Venter Institute (JCVI) ... Synthesis and Biosecurity: Lessons Learned and Options for the ... and Human Services guidance for synthetic biology providers has ... --> --> Synthetic biology ... potential to pose unique biosecurity threats. It now is ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... 26, 2015 --> ... 2016 - 2020 report analyzes that automating biobanking ... quality in long-term samples, minimizing manual errors, improving ... minimizes manual errors such as mislabeling or inaccurate ... it plays a vital role in blood fractionation, ...
(Date:11/25/2015)... , Nov. 25, 2015  Neurocrine Biosciences, Inc. ... Gorman , President and CEO of Neurocrine Biosciences, will ... Conference in New York . ... visit the website approximately 5 minutes prior to the ... replay of the presentation will be available on the ...
(Date:11/25/2015)... ... November 25, 2015 , ... Jessica Richman and ... early in their initial angel funding process. Now, they are paying it forward ... make early stage investments in the microbiome space. In this, they join ...
(Date:11/24/2015)... /CNW/ - iCo Therapeutics ("iCo" or "the Company") (TSX-V: ... the quarter ended September 30, 2015. Amounts, unless ... presented under International Financial Reporting Standards ("IFRS"). ... Andrew Rae , President & CEO of ... only value enriching for this clinical program, but ...
Breaking Biology Technology: